Classification of Heart Failure in Children
Evaluation of Severity of Heart Failure in Children Attending Cardiology Unit, Assiut University Children Hospital
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Heart failure (HF) has been defined as an abnormality of cardiac structure or function leading to failure of the heart to deliver oxygen at a rate commensurate with the requirements of the metabolizing tissues, despite normal filling pressures (or only at the expense of increased filling pressures). Heart failure may result from ventricular pump dysfunction, volume overload with preserved pump function, and pressure overload with preserved pump function.Determinations of the degree of heart failure severity are essential for clinical assessment and treatment evaluation. Remarkably, no readily applied standardized method of quantifying heart failure severity exists for pediatric patients. Although standard index methods from the adult population, such as the New York Heart Association Classification, have been applied to non-infant pediatric populations, none have been validated in children. The NYHA classification measures functional capacity, not heart failure severity. The NYHA classification is inappropriate for use in pediatrics because functional capacity and responses to heart failure states differ in children compared with adults. Children have markedly different cardiac physiology, clinical presentations, and compensatory mechanisms. Moreover, the etiologies of heart failure in children are very different from those in adults. For these reasons, Ross et al.,developed a scale that is useful for grading heart failure severity in infants from birth to 6 months of age but is not applicable to older children and adolescents (Original Ross Classification).
Many have since used the "Ross Classification," including Wu et al., who confirmed an incremental rise in PNE (Plasma Norepinephrine) concentrations and progressive down-regulation of β-receptor density in children with increasing Ross class. In 1994, the Canadian Cardiovascular Society's Consensus Conference statement on the "Diagnosis and Management of Heart Failure," adopted the Ross Classification as their official scoring system for children. Ross propose an age-based Ross classification using the original variables that proved to be sensitive and specific and adding the new evidence-based data. The age ranges of 0-3 months, 4-12 months, 1-3 years, 4-8 years, and 9-18 years were chosen because the variables in the classification are generally stable during these periods but vary between them. The scoring system can be used as a continuous data set for comparison with outcomes, or it can be categorized by points.
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: abanob wadee
- Phone Number: 00+20 01224196075
- Email: wadeeabanob@yahoo.com
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Cases admitted at Pediatric Cardiology Unit, Assiut University with Heart Failure Manifestations.
Exclusion Criteria:
- Primary liver diseases.
- Hematological diseases associated with organomegaly.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of Severity of Heart Failure in Children Attending Cardiology Unit, Assiut University Children Hospital
Time Frame: baseline
|
Evaluation of Severity of Heart Failure in Children Attending Cardiology Unit, Assiut University Children Hospital using Age based Ross classification
|
baseline
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- age based ross classification
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
NCT07634822Not yet recruitingHeart Failure | Diastolic Heart Failure | Systolic Heart Failure
-
NCT07199088RecruitingAcute Decompensated Heart Failure | Heart Failure, Diastolic | Heart Failure, Systolic
-
NCT07356843RecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)
-
NCT03157219UnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart Failure
-
NCT02084992CompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart Failure
-
NCT07263035RecruitingHeart Failure | Heart Failure Acute | Acute Heart Failure (AHF) | Heart Failure - NYHA II - IV
-
NCT03387813CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive
-
NCT04281849CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure Acute
-
NCT07547540Not yet recruitingHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic
-
NCT00123955CompletedHeart Failure, Congestive | Diastolic Heart Failure
Clinical Trials on echocardiography
-
NCT07416279RecruitingHeart Disease | Cardiac Catheterisation | HFpEF - Heart Failure With Preserved Ejection Fraction
-
NCT03811730Recruiting
-
NCT04559243RecruitingNon-valvular Atrial Fibrillation | Embolic Stroke
-
NCT03275220Unknown
-
NCT01734174Withdrawn3D Transesophageal and Transthoracic Echocardiogram
-
NCT04103008UnknownMyocardial Infarction | Left Ventricular Dysfunction | Echocardiography 2D
-
NCT03264183CompletedEchocardiography, Transesophageal | Ventricular Function, Right
-
NCT06127082Not yet recruiting
-
NCT06054126RecruitingDiabetes Mellitus, Type 2 | Chronic Total Occlusion of Coronary Artery
-
NCT05851053RecruitingHeart Failure | Ventricular Dysfunction | Cardiotoxicity | Neoplasm, Breast